SoftBank Vision Fund
Edit

SoftBank Vision Fund

https://visionfund.com
Last activity: 18.10.2024
Active
Our global reach, unrivaled ecosystem, and freedom-level capital help founders build market-leading companies.
Portfolio
19
Mentions
159
Employees: 11-50
Investment Stage: Series C; Series D; Series E

Portfolio 19

DateNameWebsiteTotal RaisedLocation
25.05.2023eFisheryefishery.com$428MIndonesia,...
17.06.2022Vendrvendr.com$216MUnited Sta...
07.04.2022Fetch - Lo...fetch.com$240MUnited Sta...
01.03.2022Weee!sayweee.com$776MUnited Sta...
14.12.2021Symboticsymbotic.com$5.5BUnited Sta...
28.09.2021Opentronsopentrons.com$210MUnited Sta...
23.09.2021Advance In...advancegroup.com$480MSingapore
14.09.2021Sendososendoso.com$150.7MUnited Sta...
04.08.2021CMR Surgic...cmrsurgical.com$1.16BUnited Kin...
29.07.2021Go1go1.com$448MAustralia,...
Show more

Mentions in press and media 159

DateTitleDescription
18.10.2024Eruditus: $150 Million (Series F) Raised To Make Education Accessible And AffordableEruditus, a leader in making high-quality education accessible and affordable to individuals, companies, and governments, announced today that it has raised a $150 million Series F fundraise led by TPG’s The Rise Fund with participation fro...
07.10.2024Whatfix rolls out $58 Mn liquidity event for employees and investorsWhatfix, a digital adoption platform (DAP), has introduced a $58 million liquidity program for its employees and investors. This marks the company’s fourth buyback of employee stock options (ESOPs). The Bengaluru-based company stated that e...
30.09.2024MinIO Launches New MinIO Learning SubscriptionUnlimited access to training materials empowers enterprise customers to accelerate time-to-market for AI and data-driven applications REDWOOD CITY, Calif., Sept. 30, 2024 /PRNewswire/ -- MinIO, the leader in high-performance object storage ...
26.09.2024Whatfix: Digital Adoption Platform Company Raises $125 Million (Series E)Whatfix (see Pulse 2.0 profile), a leader among digital adoption platforms (DAPs), announced it had secured $125 Million in a Series E funding round led by Warburg Pincus, with participation from existing investor SoftBank Vision Fund 2. An...
26.09.2024Whatfix Secures USD 125 Mn in Series E Funding Led by Warburg Pincus, Aiming for Global Expansion The fresh funding will support category expansion, product innovation, and integrated product suite de...Digital adoption platform (DAP) provider Whatfix has raised USD 125 million in a Series E funding round led by Warburg Pincus, with participation from existing investor SoftBank Vision Fund 2. This latest investment brings the Bengaluru-bas...
25.09.2024Whatfix Raises $125M in Series E FundingWhatfix, a San Jose, CA-based global digital adoption platform, secured $125M in Series E funding. The round was led by Warburg Pincus with participation from existing investor SoftBank Vision Fund 2. The company intends to use the funds to...
12.09.2024Glean: Enterprise AI Company Raises $260 Million (Series E) At $4.6 Billion ValuationEnterprise AI company Glean has announced an over $260 million Series E round at a $4.6 billion valuation, as the company meets the growing demand for its Work AI platform. This funding round was co-led by Altimeter and DST Global, with par...
09.09.2024Стартап в сфере клеточной терапии ArsenalBio привлек $325 млнВ раунде финансирования Arsenal Biosciences приняли участие новые инвесторы ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures (венчурное подразделение NVIDIA), Luma Group, фонды, консультируемые T. Rowe Price...
04.09.2024ArsenalBio Raises $325M in Series C FundingArsenalBio, a San Francisco, CA-based clinical stage programmable cell therapy company, raised $325M in Series C funding. The round was led by ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures, Luma Group, fu...
04.09.2024ArsenalBio: $325 Million (Series C) To Enhance Programmable Cell Therapy ProgramsArsenal Biosciences, a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced today the closing of an oversubscribed $325 million Series C financing round. This fund...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In